Israel Active

Tel Aviv University researchers used smart sensors from Israel’s BioBeat to measure physiological reactions of 160 subjects to the second dose of the Pfizer vaccine. They showed that side effects increased over a 48-hour period, often contradicting reports of the patients themselves.

Experts from Tel Aviv University have shown that common dietary supplements can help protect us against the Covid virus as well as several common winter illnesses. They include Zinc and Copper, combined with flavonoids – polyphenolic compounds found in vegetables such as pumpkins & peas.  

The latest Coronavirus wave is over as far as Israel is concerned. Experts say the reasons include immunity from the previous Omicron wave, plus behavioral factors such as protecting the elderly. If there are no significant variants on the horizon, Israel is in a good place (and is a good place to visit!)

Researchers at Tel Aviv University have developed a 2-in-1 anti-cancer nanoparticle. It is the world’ first RNA-based treatment to combine chemotherapy to destroy cancer cells and immunotherapy to stimulate the immune system to identify and attack the remaining cancer cells.

Israeli doctors delivered by Caesarian section the first baby born at the “Shining Star” Israeli field hospital in Ukraine. Mother and baby are doing well.

Arab-Israeli Amir Zoabi heads up the laboratory at the Israeli field hospital in Ukraine. Set-up in an unused schoolroom, his lab can conduct any required test. In this article Amir shares his feelings about being part of the Israeli humanitarian delegation.

Doctors at Jerusalem’s Shaare Zedek Medical Center have performed the first implant of the thinnest artificial cornea ever printed in the world. The 50-micron thick EndoArt implant (see previously) reduces recovery time and risk of rejection. The patient had a previous human cornea rejected.

Israel’s Aidoc (see previously) has received US FDA approval for its newly developed X-ray solution that detects cases of pneumothorax (collapsed lung) on X-rays for more efficient triage. Fast diagnosis of the condition can prevent subsequent respiratory or cardiac failures.

Scientists at Israel’s Weizmann Institute have improved a cancer therapy that killed tumors but was too toxic for use.  They added a specially created antibody that targets only the CD40 receptor protein molecule which stimulates the immune system to fight the cancer.

Scientists at Israel’s Weizmann Institute have discovered that in addition to cancer-fighting T-cells, the immune system’s B-lymphocytes also produce antibodies that take part in battles against cancer cells. They target the enzyme MMP14, a cause of metastasis and can be used in future therapies.